LIFEBRIDGE 10000, LLC

Team leader for development of the LB10000 system and ongoing innovations in the area of Tumor Treating Fields. Mr. Watkins received his B.S.E.E. and M.S.E.E. from the University of New Mexico. He has over 40 years’ experience in developing new high-tech products. He held the position of Electrical Engineering Manager at Northrop Grumman Corp, where he was responsible for overseeing the work of 30 electrical engineers. Mr. Watkins carries top-secret clearance and worked on the Trident Missile while at Gulton Industries. He has also written a book on how to convert gas-powered vehicles to all electric. Mr. Watkins brings a wealth of experience and team-building knowledge to LifeBridge.

Founder & CEO 40 years of experience in entrepreneurship, with strong background in marketing and customer loyalty research. Mr. Travers earned his Bachelor’s degree in Communication from the University of Central Florida. He has started several firms from scratch, including a medical patient education company that sold training materials he produced to over 3,000 of the nation’s hospitals over a 12-year period. Mr. Travers established a marketing program that achieved over 1,000,000 viewers per year on the closed-circuit television systems of over 1,000 hospitals nationwide. Mr Travers has served has the managing Member of Loyalty Based Innovations, LLC the Intellectual Property firm holding and licensing patents, since Jan of 2015 Mr Travers has served as the managing member of Comprehensive Innovations, LLC, his personal holding company and majority owner of Lifebridge 10000, LLC since 2015 Mr Travers serves as the managing member of LifeBridge 10000, LLC Since Jan 2015. The company of this offering providing cancer therapies. Mr Travers has served has the CEO of Comprehensive Loyalty, INC since August of 2002. The firm specializes in customer loyalty and predictive models for retail site selection

Consults on the LB10000 prototype design and ongoing innovations in the area of Tumor Treating Fields. Mr. VanderMey earned his B.S degree in Mechanical Engineering from Geneva College with Math and Electrical Engineering minors. He is the founder and president of Proton Design, a firm that provides engineering design consulting. He led a 15-member engineering department while with the Intellon Corporation. His work has achieved many patents for both him and his clients. He recently designed a medical device to measure pressure during tracheal intubation. Mr. VanderMey developed the original design for the LB10000.

Avi Roop is the Chairman of the Board and CEO of Miret Surgical Inc., a Managing Member of ExoToe LLC, and a Partner with Surgical Design Innovations. His twenty-year career in surgical and interventional device markets encompasses ten years at 2 large-caps and ten years at 5 start-ups. Three of the five start-ups were sold to strategic partners; the other two are going concerns. Avi has spent fourteen years in customer-facing roles spanning senior management, corporate marketing, and product development. He possesses extensive experience in early-stage development from unmet need identification to early commercialization. During his career, he has been named on twenty-four issued US patents and more than 35 issued patents globally. Avi completed the Stanford Biodesign Fellowship supported by the Cottrell, Kauffman and Lucile Packard Foundations, received an MBA from the Haas School of Business at UC Berkeley and received a BS Mechanical Engineering from the University of Minnesota Institute of Technology.

Ms. LaTour has been successful in starting and building new ventures, repositioning under-performing organizations, identifying and negotiating mergers and acquisitions for successful companies, and restarting failing businesses. She currently serves as an Operating Partner for LFE Capital, Naples, FL and Minneapolis, MN and the Managing Partner of LaTour & Associates, an international consulting firm focused on innovative business development. Previously she served as President & CEO of World Telehealth Corporation, an online healthcare company serving the G77 countries; CEO of ContourPak International, a cold therapy healthcare products company (acquired by Futuro); Founder, CEO and President of Theranetics, Inc., a physical therapy media products company (acquired by Kaiser Permanente); President & CEO of numerous tech companies. Ms. LaTour currently serves as Chairman of the Board, Earthrise Space Inc.; Board Member of Zuke Music Inc.; and Karman Space Inc.; and Board Observer for TAO Connect Inc., and Mend Software Inc. She also serves on community boards at Crummer Business School Entrepreneurial Program at Rollins College; the Regional Joint Partnership Capital Task Force for Orlando, Inc., and BizLife and Factur. Ms. LaTour holds a B.S. in Mathematics from University of California, Los Angeles, M.S. degrees in Mathematics & Behavioral Psychology from University of Southern California, and is a graduate of the Advanced Management Program at Harvard University.

Mr. Abt has 23 years of experience in financial and accounting roles with General Electric Credit, Martin Marietta, and several non-profits. He has a business management degree from UCF and started his career after college with Mr. Travers’ first start-up as his office manager/bookkeeper. He works part-time as LifeBridge 10000’s bookkeeper. Mr. Abt has 23 years of experience in financial and accounting roles with General Electric Credit, Martin Marietta, and several non-profits.

Dr. Lee Zehngebot has served as the Director of Clinical Research, Florida Hospital Cancer Institute in Orlando since 2007 and has participated as Principal Investigator and Co-Investigator on numerous clinical studies. In 2008, he helped Florida Hospital to earn a Clinical Trials Participation National Award from the American Society of Clinical Oncology (ASCO).Published in prestigious journals such as the Journal of Clinical Oncology, Cancer and Annals of Oncology; recognized with a regional award as one of the Best Doctors in America. Dr. Zehngebot has expressed an interest in being the principle investigator for our phase 1 clinical trial once FDA requirements have been met.

Mr. Hubbard provides advice on most aspects of LifeBridge’s business model and research efforts. He provides business contacts and will play a major role in advising the structure and organization of the Phase 1 clinical trial. Scott has over 20 years’ experience in the medical device industry. He is presently the Senior Director of Business Development/Partnerships for Merge eClinical, an IBM Company that streamlines data collection and analysis for clinical trials globally. Prior to his present position, he was the Director of Business Development, Medical Devices and Diagnostic Research for ICON plc, the fifth largest clinical research company in the world, with over 10,000 employees in 38 countries.